%0 Journal Article
%T COVID-19 Vaccination Status and Severe Outcomes among Patients Hospitalized for COVID-19 in West Africa, Togo, 2021
%A Aw¨¨r¨¦ou Kotosso
%A Yao Rodion Konu
%A Lidaw D¨¦assoua Bawe
%A Sarakawabalo Assenouwe
%A Yawovi Mawufemo Tsevi
%A Koffi Atsu Aziagbe
%A Akouda Akessiwe Patassi
%A Bawoubadi Abaltou
%A Gnimdou Tchamdja
%A Lampouguini Nebona
%A Komi S¨¦raphin Adjoh
%A Didier Ekouevi
%A Majest¨¦ Ihou Wateba
%J Advances in Infectious Diseases
%P 87-104
%@ 2164-2656
%D 2024
%I Scientific Research Publishing
%R 10.4236/aid.2024.141008
%X <strong>Objectives:</strong> More than a year after its introduction, COVID-19 vaccination coverage was low in the Togolese population and little data were available on its benefits for hospitalized patients. This study aimed to describe the impact of COVID-19 vaccination on the prognosis of hospitalized patients.<strong> Methods: </strong>This was a retrospective cohort study of patients admitted to the Centre Hospitalier R¨¦gional Lom¨¦ Commune (Togo) between June 1, 2021 and May 31, 2022. Primary outcomes (admission to the intensive care unit and death) were presented with frequency and proportion. Mortality rates were presented by sociodemographic and clinical characteristics and compared by appropriate statistical tests. Factors associated with inpatient death were described by performing a Cox proportional hazard regression. <strong>Results: </strong>A total of 604 patients were hospitalized (50.0% women). The mean age was 54.03 ¡À17.1 years. Only 55 patients were fully vaccinated (9.1%). ICU admission was significantly more frequent in unvaccinated patients than in vaccinated ones (63.0% vs. 38.2%; p &lt; 0.001). Overall, 172 patients died (28.5%) and the mortality rate was significantly lower in vaccinated than in unvaccinated patients (9.1% vs. 30.4%; p &lt; 0.001). The 15 and 30-day mortality rates for all the patients were 26.1% and 28.3% respectively. The instantaneous risk of death was 73.0% lower in fully vaccinated patients (aHR = 0.27 [95% confidence interval (0.11 - 0.67)]). <strong>Conclusion: </strong>COVID-19 vaccination had a significant benefit for patients with COVID-19 infection in terms of reducing the risk of death. Based on real-world data from sub-Saharan Africa, this information can help optimize the benefit of COVID-19 vaccination by raising community awareness and increasing vaccine coverage while reducing hesitancy.
%K COVID-19
%K Vaccination
%K Prognosis
%K Mortality
%K Sub-Saharan Africa
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=130927